S
Sonia M. Davis
Researcher at University of North Carolina at Chapel Hill
Publications - 80
Citations - 19288
Sonia M. Davis is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Antipsychotic & Risperidone. The author has an hindex of 49, co-authored 80 publications receiving 18120 citations. Previous affiliations of Sonia M. Davis include North Carolina Department of Health and Human Services & Harvard University.
Papers
More filters
Journal ArticleDOI
Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules
TL;DR: This work simultaneously estimates the optimal individualized treatment rule for all composite outcomes representable as a convex combination of the (suitably transformed) outcomes and proves that as the number of subjects and items on the questionnaire diverge, the estimator is consistent for an oracle optimal individualization treatment rule wherein each patient's preference is known a priori.
Journal ArticleDOI
Employment Outcomes in a Randomized Trial of Second-Generation Antipsychotics and Perphenazine in the Treatment of Individuals with Schizophrenia
Sandra G. Resnick,Robert A. Rosenheck,José M. Cañive,Cyril De Souza,T. Scott Stroup,Joseph P. McEvoy,Sonia M. Davis,Richard S.E. Keefe,Marvin S. Swartz,Jeffrey A. Lieberman +9 more
TL;DR: There were no differences between medication groups on employment outcomes or participation in PSR among these five medications, including the FGA perphenazine.
Journal ArticleDOI
Second-generation antipsychotics: reviewing the cost–effectiveness component of the CATIE trial
Robert A. Rosenheck,Marvin S. Swartz,Joseph P. McEvoy,T. Scott Stroup,Sonia M. Davis,Richard S.E. Keefe,John K. Hsiao,Jeffrey A. Lieberman +7 more
TL;DR: Results of CATIE are robust to potential methodological limitations and perphenazine seems to have been a more representative choice for first-generation antipsychotic comparison treatment than haloperidol.
Journal ArticleDOI
Self-reported and accelerometer-measured physical activity by body mass index in US Hispanic/Latino adults: HCHS/SOL.
Priya Palta,Robert G. McMurray,Natalia Gouskova,Daniela Sotres-Alvarez,Sonia M. Davis,Mercedes R. Carnethon,Sheila F. Castañeda,Marc D. Gellman,Arlene L. Hankinson,Carmen R. Isasi,Neil Schneiderman,Greg Talavera,Kelly R. Evenson +12 more
TL;DR: Efforts are needed to reach the Hispanic/Latino population to increase opportunities for an active lifestyle that could reduce obesity in this population at high risk for metabolic disorders.
Journal ArticleDOI
Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis.
Suresh Venkateswaran,Jarod Prince,David J. Cutler,Urko M. Marigorta,David T. Okou,Sampath Prahalad,David R. Mack,Brendan M. Boyle,Thomas D. Walters,Anne M. Griffiths,Cary G. Sauer,Neal S. Leleiko,David J. Keljo,James Markowitz,Susan S. Baker,Joel R. Rosh,Marian Pfefferkorn,Melvin B. Heyman,Ashish S. Patel,Anthony R. Otley,Robert N. Baldassano,Joshua D. Noe,Paul A. Rufo,Maria Oliva-Hemker,Sonia M. Davis,Michael E. Zwick,Greg Gibson,Lee A. Denson,Jeffrey S. Hyams,Subra Kugathasan +29 more
TL;DR: The paramount importance of antigenic stimulation either by infectious or noninfectious stimuli as a causal event in pediatric UC onset is speculated, and the HLA association is approximately twice as strong in Pediatrics compared with adults, due to a combination of novel and shared effects.